Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Seiwert, Tanguy Y, Dr, Burtness, Barbara, MD, Mehra, Ranee, Weiss, Jared, MD, Berger, Raanan, MD, Eder, Joseph Paul, MD, Heath, Karl, MPH, McClanahan, Terrill, PhD, Lunceford, Jared, PhD, Gause, Christine, PhD, Cheng, Jonathan D, MD, Chow, Laura Q, MD
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
Rugo, Hope S., Trédan, Olivier, Ro, Jungsil, Morales, Serafin M., Campone, Mario, Musolino, Antonino, Afonso, Noémia, Ferreira, Marta, Park, Kyong Hwa, Cortes, Javier, Tan, Antoinette R., Blum, Joanne L., Eaton, Lamar, Gause, Christine K., Wang, Zhen, Im, Ellie, Mauro, David J., Jones, Mary Beth, Denker, Andrew, Baselga, José
Published in Breast cancer research and treatment (01.10.2017)
Published in Breast cancer research and treatment (01.10.2017)
Get full text
Journal Article
Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience
Liao, Jason J.Z., Farooqui, Mohammed Z.H., Marinello, Patricia, Hartzel, Jonathan, Anderson, Keaven, Ma, Junshui, Gause, Christine K.
Published in Contemporary clinical trials (01.12.2020)
Published in Contemporary clinical trials (01.12.2020)
Get full text
Journal Article
MP68-11 A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED UROTHELIAL CANCER
Gupta, Shilpa, O'Donnell, Peter, Plimack, Elizabeth R, Berger, Ranaan, Montgomery, Bruce, Heath, Karl, Dolled-Filhart, Marisa, Pathiraja, Kumudu, Gause, Christine K, Cheng, Jonathan, Perini, Rodolfo, Bellmunt, Joaquim
Published in The Journal of urology (01.04.2015)
Published in The Journal of urology (01.04.2015)
Get full text
Journal Article
Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women
Barr, Eliav, MD, Gause, Christine K., PhD, Bautista, Oliver M., PhD, Railkar, Radha A., PhD, Lupinacci, Lisa C., PhD, Insinga, Ralph P., PhD, Sings, Heather L., PhD, Haupt, Richard M., MD, MPH
Published in American journal of obstetrics and gynecology (01.03.2008)
Published in American journal of obstetrics and gynecology (01.03.2008)
Get full text
Journal Article
Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC
Diaz, Luis A., Marabelle, Aurelien, Delord, Jean-Pierre, Shapira-Frommer, Ronnie, Geva, Ravit, Peled, Nir, Kim, Tae Won, Andre, Thierry, Van Cutsem, Eric, Guimbaud, Rosine, Jaeger, Dirk, Elez, Elena, Yoshino, Takayuki, Joe, Andrew K., Lam, Baohoang, Gause, Christine K., Pruitt, Scott Knowles, Kang, S. Peter, Le, Dung T
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Efficacy analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanoma
Long, Georgina V., Dummer, Reinhard, Ribas, Antoni, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert Hans Ingemar, Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan S., Fernandez, Eugenio, Kirkwood, John M., Gajewski, Thomas, Gause, Christine K., Chen, Lisa, Gorski, Kevin, Anderson, Abraham, Kaufman, David Ross, Chou, Jeffrey, Hodi, F. Stephen
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
Brahmer, Julie R., Long, Georgina V., Hamid, Omid, Garon, Edward B., Herbst, Roy S., Andre, Thierry, Armand, Philippe, Bajorin, Dean, Bellmunt, Joaquim, Burtness, Barbara, Choueiri, Toni K., Cohen, Ezra E.W., Diaz, Luis A., Shitara, Kohei, Kulkarni, Girish, McDermott, David, Shah, Manish, Tabernero, Josep, Vogel, Arndt, Zinzani, Pier Luigi, Jafari, Niusha, Bird, Steven, Snyder, Ellen, Gause, Christine, Bracco, Oswaldo L., Pietanza, M. Catherine, Gruber, Todd, Ribas, Antoni
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer
Baselga, José, Morales, Serafin M., Awada, Ahmad, Blum, Joanne L., Tan, Antoinette R., Ewertz, Marianne, Cortes, Javier, Moy, Beverly, Ruddy, Kathryn J., Haddad, Tufia, Ciruelos, Eva M., Vuylsteke, Peter, Ebbinghaus, Scot, Im, Ellie, Eaton, Lamar, Pathiraja, Kumudu, Gause, Christine, Mauro, David, Jones, Mary Beth, Rugo, Hope S.
Published in Breast cancer research and treatment (01.06.2017)
Published in Breast cancer research and treatment (01.06.2017)
Get full text
Journal Article
VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Siegel, David S, Dimopoulos, Meletios, Jagannath, Sundar, Goldschmidt, Hartmut, Durrant, Simon, Kaufman, Jonathan L, Leleu, Xavier, Nagler, Arnon, Offner, Fritz, Graef, Thorsten, Eid, Joseph E, Houp, Jennifer, Gause, Christine, Vuocolo, Scott, Anderson, Kenneth C
Published in Clinical lymphoma, myeloma and leukemia (01.06.2016)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2016)
Get full text
Journal Article
Pembrolizumab (MK-3475) plus low-dose ipilimumab (IPI) in patients (pts) with advanced melanoma (MEL) or renal cell carcinoma (RCC): Data from the KEYNOTE-029 phase 1 study
Atkins, Michael B., Choueiri, Toni K., Hodi, F. Stephen, Thompson, John A., Hwu, Wen-Jen, McDermott, David F., Brookes, Melissa, Tosolini, Alessandra, Ebbinghaus, Scot, Yang, Zijiang, Gause, Christine K., Perini, Rodolfo F., Ribas, Antoni
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A multicenter, open-label trial of talimogene laherparepvec (T-VEC) plus pembrolizumab vs pembrolizumab monotherapy in previously untreated, unresected, stage IIIB-IV melanoma
Ribas, Antoni, Puzanov, Igor, Gajewski, Thomas, Long, Georgina V., Dummer, Reinhard, Kirkwood, John M., VanderWalde, Ari, Cebon, Jonathan S., McArthur, Grant A., Gause, Christine K., Chen, Lisa, Kaufman, David Ross, Chou, Jeffrey, Andtbacka, Robert Hans Ingemar, Hodi, F. Stephen
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer
Bellmunt, Joaquim, Sonpavde, Guru, De Wit, Ronald, Choueiri, Toni K., Siefker-Radtke, Arlene O., Plimack, Elizabeth R., Lewis, Nicole M., Brown, Holly, Mai, Yabing, Gause, Christine K., Kaufman, David Ross, Bajorin, Dean F.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab
Powell, Steven Francis, Liu, Stephen V., Sukari, Ammar, Chung, Christine H., Bauml, Joshua, Haddad, Robert I., Gause, Christine K., Niewood, Michelle, Gammage, Linda L., Brown, Holly, Meister, Amy, Cheng, Jonathan D., Gitau, Mark M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
KEYNOTE-040: A phase III randomized trial of pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer
Cohen, Ezra E. W., Machiels, Jean-Pascal H., Harrington, Kevin J., Burtness, Barbara, Shin, Sang Won, Gause, Christine K., Swift, Ann M., Brown, Holly, Perrone, Andrea Marie, Cheng, Jonathan D., Swaby, Ramona F., Le Tourneau, Christophe
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract PD5-1: Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer
Rugo, Hope S, Tredan, Olivier, Ro, Jungsil, Morales, Serafin, Musolino, Antonino, Afonso, Noemia, Ferreira, Marta, Park, Kyong Hwa, Cortes, Javier, Tan, Antoinette R, Blum, Joanne L, Eaton, Lamar, Gause, Christine K, Wang, Adelle (Zhen), Im, Ellie, Mauro, David J, Baselga, José
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer
Nanda, Rita, Chow, Laura Q, Dees, E Claire, Berger, Raanan, Gupta, Shilpa, Geva, Ravit, Pusztai, Lajos, Dolled-Filhart, Marisa, Emancipator, Kenneth, Gonzalez, Edward J, Houp, Jennifer, Pathiraja, Kumudu, Karantza, Vassiliki, Iannone, Robert, Gause, Christine K, Cheng, Johnathan D, Buisseret, Laurence
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Pembrolizumab (Pembro; MK-3475) for advanced urothelial cancer: Results of a phase IB study
O'Donnell, Peter H., Plimack, Elizabeth R., Bellmunt, Joaquim, Berger, Raanan, Montgomery, Robert B., Heath, Karl, Dolled-Filhart, Marisa, Pathiraja, Kumudu, Gause, Christine K., Cheng, Jonathan D., Perini, Rodolfo F., Gupta, Shilpa
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article